Pharmaceutical companies are spending millions of dollars on private deals with US hospital systems that give them access to patient genetic information that could spur innovation. Patients may like the idea of free genetic testing but not be fully aware of all of the ways their genetic data is being used, and the deals raise issues about disclosures and profits.
Private deals give pharma access to patient genetic data
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.